The study has shown that glioma induces chronic inflammation in microglia and activates Toll-like receptor 2 (TLR2), triggering downstream MAPK/ERK signaling, and responses associated to loss of histone H3 acetylation at CIITA promoters (20). The gene discussed is CIITA; the disease is central nervous system cancer.